Ono to Offer New Invoice Prices for Opdivo Early on to Avoid Distribution Confusion

Ono Pharmaceutical will sell its immuno-oncology med Opdivo (nivolumab) to drug wholesalers at new invoice prices before the 50% reduction in its NHI reimbursement prices takes effect in February so as to ward off confusion in its distribution, a company...read more